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Abstract
Purpose: Besides its application in oncology, 18F-FDG PET-CT imaging is also useful in the diagnosis of certain lung
infections, inflammatory diseases, and atherosclerotic plaques. Myocardial uptake of 18F-FDG may hamper visualization of
the lesions caused by these diseases. Two approaches have been proposed for reducing myocardial uptake in preclinical
studies, namely, calcium channel blockers (verapamil) and high-fat diets such as commercial ketogenic diets and sunflower
seed diets. The objective of this study was to compare the efficacy of these approaches in reducing myocardial uptake of
18F-FDG in mice.
Methods: We performed two experiments. In experiment A, each animal underwent four 18F-FDG PET/CT scans in the
following order: baseline, after administration of verapamil, after two days on ketogenic diet and after two days on
sunflower seeds. PET scans were performed 60 minutes after injection of 18.5 MBq of 18F-FDG. In experiment B, the best
protocol of the three (ketogenic diet) was evaluated in a lung inflammation model to assess the efficacy of reducing
myocardial uptake of 18F-FDG.
Results: Compared with baseline (SUV 2.0361.21); the greatest reduction in uptake of 18F-FDG was with ketogenic diet (SUV
0.7960.16; p = 0.008), followed by sunflower seeds (SUV 0.9160.13; p = 0.015); the reduction in myocardial uptake produced
by verapamil was not statistically significant (SUV 1.7860.79; p =NS). In experiment B, complete suppression of myocardial
uptake noticeably improved the visualization of inflamed areas near the heart, while in the case of null or partial myocardial
suppression, it was much harder to distinguish lung inflammation from myocardial spillover.
Conclusion: A high-fat diet appeared to be the most effective method for decreasing myocardial uptake of 18F-FDG in
healthy mice, outperforming verapamil. Our findings also demonstrate that ketogenic diet actually improves visualization of
inflammatory lesions near the heart.
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Introduction
Positron emission tomography (PET) with 2-deoxy-2-
(18F)fluoro-D-glucose (18F-FDG) is an essential tool in oncology
imaging [1]. Given that both tumor and immune cells have high
glucose metabolism, the role of 18F-FDG-PET/computed tomog-
raphy (CT) is being expanded in clinical practice for the detection
of inflammatory and infectious diseases. However, some organs,
such as the heart, brain, and liver, also have high glucose
metabolism and, consequently, show high 18F-FDG uptake in the
absence of disease. Interference from myocardial uptake may
hamper visualization of lesions – and thus diagnosis – in several
diseases, such as visualization of carotid plaques or pulmonary or
cardiac inflammatory/infectious (e.g., endocarditis) [2] and lung
infections (e.g., tuberculosis). Minimizing myocardial uptake of
18F-FDG can improve detectability of lesions in the middle
pulmonary lobe and adjacent mediastinal tissues and decrease the
number of false-positive readings [3,4,5]. The two main mecha-
nisms for reducing myocardial uptake of 18F-FDG are switching
myocardial metabolism to free fatty acids (FFAs) and blocking
glucose transport into cardiomyocytes.
The first mechanism takes advantage of the ability of the
myocardium to switch its metabolism from glucose to FFAs in
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order to reduce myocardial 18F-FDG needs. This is possible
because cardiomyocytes can use a variety of energy sources, such
as FFAs, glucose, lactate, and ketone bodies.
In fasting states, or under high-fat diets, heart energy
production is primarily based on FFAs (Randle cycle) rather than
on glucose metabolism. Conversely, the ingestion of carbohydrates
or glucose raises plasma concentrations of insulin and glucose and
reduces the availability of FFAs in the myocardium [2,6].
Alternatively, a pharmacological approach could facilitate patient
cooperation; heparin, for instance, is known to increase the
concentration of FFAs in blood [7].
Nowadays, clinical protocols to reduce myocardial uptake of
18F-FDG are moving from fasting-based methods to dietary
protocols (low-carbohydrate or low-carbohydrate plus high-fat
diets), because a substantial reduction in myocardial uptake
requires long fasting periods that make patient cooperation
problematic [8]. On the other hand, one night on a low-
carbohydrate, high-fat diet seems sufficient to ensure good
myocardial suppression [9]. Despite efforts to standardize patient
preparation before PET studies, myocardial uptake of 18F-FDG
has proven highly variable in both clinical and preclinical
applications owing to individual patient characteristics [10,11] or
to differences in animal handling [12,13].
Blocking glucose transport into cardiomyocytes can also use to
suppress myocardial uptake of 18F-FDG. Verapamil is a calcium
channel antagonist that modulates the influx of calcium across the
membrane of the arterial smooth muscle cells and cardiomyocytes.
It is used to treat hypertension, angina pectoris, and cardiac
arrhythmia. Verapamil reduces myocardial glucose uptake by
blocking calcium channels. In a preclinical study, administration of
verapamil before 18F-FDG led to a significant reduction in
myocardial uptake in healthy mice [14].
Both approaches – high-fat diets and verapamil – are thought to
considerably reduce myocardial uptake of 18F-FDG; however, to
our knowledge, no comparative studies have been performed. The
primary objective of our work was to assess (both quantitatively
and visually) and compare the efficacy of high-fat diets and
verapamil to suppress myocardial uptake of 18F-FDG in healthy
mice. Our secondary objective was to evaluate the usefulness of the
method for improving the detectability of lesions in a murine lung
inflammation model.
Material and Methods
Ethics statement
All animal procedures were approved by the Animal Experi-
mentation Ethics Committee of Hospital General Universitario
Gregorio Maran˜o´n, Madrid, Spain and were performed according
to EU directive 2010/63/EU and national regulations (RD 53/
2013).
Experimental procedures
Ten female C57BL/6 mice aged eight weeks (Harlan Labora-
tories) were housed in cages under standard environmental
conditions and allowed food and water ad libitum. As the
experimental workflow shows (Fig. 1), two experiments were
carried out in this study. In experiment A, each animal underwent
four 18F-FDG PET/CT scans as follows: baseline, after admin-
istration of verapamil, after two days on a ketogenic diet, and after
two days on a sunflower seed diet. Mice returned to their regular
diet (A04, SAFE) for four days between each treatment or change
in diet.
Once experiment A was completed, the resulting best protocol
was evaluated in a lung inflammation model (n = 10) to assess the
efficacy of reducing myocardial uptake of 18F-FDG (Fig. 1
Experiment B).
Verapamil. Mice received a single intraperitoneal dose of
1.3 mg/kg (Manido´n 2.5 mg/2 ml) one hour before administra-
tion of 18F-FDG [14].
Diets. Two high-fat diets were tested in this study: a
commercial ketogenic diet (TD 96355, Harlan) and a sunflower
seed diet (Euricar Europa, S.L.). The ketogenic diet is very high-fat
(90%/0.4%, fat/carbohydrates) with almost no carbohydrate,
while sunflower seeds are an intermediate fat diet (55%/18%, fat/
carbohydrates) [15].
Lung inflammation model. We administered 5 mg/kg of
lipopolysaccharide (LPS) from Escherichia coli (055:B5 Sigma-
Aldrich) diluted in 100 ml of saline into the mouse trachea under
light anesthesia with isoflurane [16]. The 18F-FDG PET scan was
performed 24 hours after the LPS challenge (Fig. 1 Experiment B).
Histopathology. Forty-eight hours after the LPS challenge
and after the last PET study, the animals were euthanized using a
CO2 chamber. The lungs were fixed in 10% neutral buffered
formalin. Sections (5 mm) of the left and right lung lobes were
placed into a tissue-processing cassette and stained with hema-
toxylin and eosin.
PET/CT imaging
All the studies were performed with a small-animal PET/CT
device (Argus, SEDECAL, Spain [17,18]). PET scans were
acquired 60 minutes after intraperitoneal administration of
19.461.02 MBq of 18F-FDG. During uptake, the animals were
kept awake and warm under infrared light to avoid brown fat
uptake. Blood glucose levels (BGLs) were measured before
administration of 18F-FDG using a glucose meter (Glucocard
TM G+ meter, A. Menarini, Spain). PET data were collected for
45 minutes with the mice anaesthetized using 1.5% isoflurane in
oxygen at 3 l/min and reconstructed using OSEM-2D with 50
subsets and 2 iterations. The voxel size of the reconstructed images
was 0.388 mm in the transaxial plane and 0.775 mm axially. After
the PET scan, a CT study was acquired using an X-ray beam
current of 240 mA and a tube voltage of 40 kVp and reconstructed
using an FDK algorithm [19]. These CT scans were used as
anatomical templates and to perform intra-subject spatial co-
registration.
Figure 1. Experimental workflow. Each box represents a day. The
numbers indicate the 18F-FDG PET/CT scans. Experiment A: (1) baseline,
(2) post-verapamil, (3) post-ketogenic diet (KD) and (4) post-sunflower
seed diet (SD). Experiment B: LPS challenge was performed 24 hours
before the PET scan (5).
doi:10.1371/journal.pone.0107999.g001
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Data analysis
Visual uptake scale. Five experts rated in a blinded fashion
the 18F-FDG myocardial uptake according to the Likert scale [5],
as follows: 0, homogeneously minimal; 1 mostly minimal or mild; 2
mostly intense or moderate; 3 homogeneously intense (Fig. 2).
Standardized uptake value (SUV). For each image, a
region of interest (ROI) was selected containing the myocardium
of the whole left ventricle (8–10 slices). The mean myocardial SUV
was calculated in each subject. In order to use exactly the same
ROIs, studies of suppressed uptake were manually co-registered to
the baseline PET scan using the CT scan of the thorax.
Lesion/myocardium ratio. For each animal on Experi-
ment B, a lesion and heart ROI were selected on a slice from the
CT study containing both lesion and heart areas. These ROIs
were applied to the co-registered PET images in order to measure
the maximum activity within each ROI and calculate the lesion/
myocardium ratio.
Statistical analysis. Agreement of the visual assessment
between experts was measured using the Cohen’s kappa coeffi-
cient. Differences between treatments were compared using a
Wilcoxon test. Data are reported as mean (6 standard deviation).
Differences in BGLs and myocardial uptake were compared
between the experimental treatments using repeated-measure-
ments one-way ANOVA with Sidak post hoc test. Data were
logarithmically transformed because they did not follow a
Gaussian distribution (Kolmogorov-Smirnov, p = 0.028 on origi-
nal myocardial data and p = 0.256 after log-transformation). The
differences between the lesion/myocardium ratios were compared
using one-way ANOVA with Sidak post hoc test. Differences were
considered statistically significant at p,0.05.
Results
Experiment A
Animals in experiment A were divided into four groups based
on uptake of 18F-FDG, measured according to Likert scale (Fig. 2).
Kappa coefficient showed a substantial agreement between experts
(0.6366), according to standard kappa interpretation [20]. This
assessment of the PET images for each treatment is shown in
Table 1. After administration of verapamil, no animal showed
complete myocardial suppression (0 on the Likert scale), whereas it
was homogeneously intense in 40% of the animals. Sunflower
seeds suppressed myocardial uptake in 40% of the animals, while
the ketogenic diet suppressed uptake in 70%. Uptake was not
intense in animals on the ketogenic diet or in animals fed
sunflower seeds. Wilcoxon tests showed significant differences
between verapamil and seed diet (p = 0.013) and between
ketogenic diet and seed diet (p = 0.037).
Quantification of myocardial SUV (Fig. 3) showed that,
compared with baseline (SUV 2.0361.21), the greatest reduction
in 18F-FDG uptake was with a ketogenic diet (SUV 0.7960.16;
p = 0.008), followed by sunflower seeds (SUV 0.9160.13;
p = 0.015); verapamil produced no significant reduction in
myocardial uptake (SUV 1.7860.79; p = NS). The differences in
uptake observed between the two diets did not reach statistical
significance (p = 0.626), p values were obtained using the Sidak
post hoc test. SUV results combined with the visual assessment
further support that ketogenic diet led to the greatest reduction in
myocardial uptake, followed by sunflower seeds.
Table 2 shows BGLs before administration of 18F-FDG for each
treatment. The ketogenic diet significantly decreased blood
glucose concentration compared with baseline and verapamil
(p = 0.04 and p = 0.004, respectively, Sidak post hoc tests).
Experiment B
After the LPS challenge, all the animals (n = 10) developed
severe respiratory problems, and two died within the first
30 hours. Positive uptake of 18F-FDG in lung tissue was recorded
in all animals 24 hours after LPS compared with baseline
(Fig. 4A). Animals in experiment B were also divided into four
groups based on the Likert scale, as described above (Fig. 2).
Myocardial uptake was completely suppressed in 50% of the
animals, 30% showed a moderate reduction, and 20% had
homogeneously intense uptake. Figure 4 shows an example of lung
inflammation according to the degree of myocardial uptake of 18F-
FDG. As expected, complete suppression of myocardial uptake
noticeably improved the visualization of hot areas near the heart
(Fig. 4D), whereas in the case of null or partial suppression, it was
much harder to distinguish inflammation from myocardial
spillover (arrows on Fig. 4B and 4C). Lesion/myocardium ratio
was higher in animals with complete myocardium suppression
(1.460.2) compared with moderate myocardium reduction
(0.7160.11; p = 0.013) and also with null reduction (0.860.03;
p = 0.006). Lung histology confirmed the existence of inflamma-
tory lesions (data not shown).
Discussion
The aim of this study was to assess the efficacy of high-fat diets
and administration of verapamil for suppression of myocardial
uptake of 18F-FDG in mice. Our results showed that, when given
over two days, both ketogenic and sunflower diets reduced
myocardial uptake of 18F-FDG significantly more than adminis-
tration of verapamil. This finding held true both visually (Table 1)
and quantitatively (Fig. 3).
Studies in humans have shown that diet protocols can suppress
myocardial uptake of 18F-FDG better than fasting methods [21]. A
Figure 2. Four-grade visual uptake scale. 0, homogeneously minimal; 1 mostly minimal or mild; 2 mostly intense or moderate; 3
homogeneously intense.
doi:10.1371/journal.pone.0107999.g002
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study by Kobayashi et al. [8] reported complete suppression in
71.4% of healthy volunteers after 24 hours of carbohydrate
restriction combined with a high-fat drink one hour before 18F-
FDG, while the remaining 28.6% showed only residual uptake of
18F-FDG by the papillary muscle. Williams and Kolodny [5]
reported a larger reduction in myocardial SUV in cancer patients
with a low-carbohydrate/high-fat dietary protocol three to
six hours before 18F-FDG than in patients following a fasting
protocol (3.963.6 and 8.865.7). Furthermore, Cheng et al. [22]
reported that a low carbohydrate diet suppressed myocardial
uptake better than a standard fasting protocol and that a low-
carbohydrate protocol was better than a low-carbohydrate/high-
fat protocol in cancer patients. The myocardial uptake values in
the control group (fasting group) reported by Cheng et al. [22]
were lower than those in Kobayashi et al. [8] and Williams et al.
[5]. The authors attributed this difference to variability in
myocardial uptake [22]. Khandani et al. [11] examined myocar-
dial variability and showed that cardiac 18F-FDG uptake did not
change on serial scans of the same patient over time, but did
change when groups of patients were compared. This variability in
myocardial uptake between patients may make it difficult to
standardize their preparation before a PET scan.
Despite the controversy surrounding reduction in myocardial
uptake in human studies, the present findings are consistent with
those of previous preclinical works. Tupper et al. [23] showed
reduced cardiac uptake in mice after 12 hours of ketogenic diet
compared with 12 hours of fasting. Fine et al. [24] compared the
effects on myocardial uptake of three diets in rats (low
carbohydrate/high-fat, 0.01%/90%; intermediate, 52%/28%;
and high carbohydrate/low fat, 78%/2%) and showed that the
low carbohydrate/high-fat diet induced a 70% reduction in
myocardial uptake. In the present study, two days on ketogenic
diet was enough to induce a 61% reduction in 18F-FDG uptake
compared with baseline, while a sunflower seed diet reduced
uptake by about 55%, perhaps because the latter has a lower
content of FFAs than the ketogenic diet. Nevertheless, cardiac 18F-
FDG can be somewhat reduced using a sunflower seed diet; in
addition, its low cost makes it a very promising option. We
hypothesize that increasing the duration of the diet by one or two
days could be enough to produce effects similar to those reported
by Fine et al. [24]. No optimal protocols for the duration of diets
have been reported to reduce myocardial 18F-FDG uptake. In
recent clinical studies, duration of diet varies between one night
[9] and 24 hours [8]. In preclinical settings, durations of 12 hours
[23] to 4 weeks [24] have been reported. Although one night
seems to be sufficient, diet protocols nowadays involve two or three
fat meals (24 hours) before the PET scan; in the case of rodents,
this could be equivalent to two nights. Our results confirm that two
days of a high-fat diet is sufficient to suppress myocardial 18F-FDG
uptake.
Diets have proven successful in mice; however, in humans, they
require good adherence, which is not always easy to achieve.
Wykrzykowska et al. [9] showed inadequate cardiac suppression in
12 of 32 patients who admitted to not adhering to their diet.
Therefore, pharmacological approaches are often used to avoid
non-adherence. Ishimura et al. [7] administered heparin before
18F-FDG to detect sarcoidosis lesions, because heparin increases
serum FFA levels and possibly minimizes background myocardial
uptake. Gaeta et al. [14] used a calcium channel blocker
(verapamil) to avoid glucose transport into cardiomyocytes and
thus reduce 18F-FDG uptake in animals. Our findings showed that
after administering verapamil one hour before injection of 18F-
FDG, only one out of ten animals exhibited minimal myocardial
uptake (0 on the Likert scale) and only two of ten obtained mostly
minimal uptake (1 on the Likert scale). However, consistent with
Gaeta et al. [14], we observed a slight (12.7%) reduction in
myocardial uptake with verapamil (Fig. 3) compared to baseline,
but the difference did not reach statistical significance. Part of this
quantitative discrepancy could be attributed to differences in
animal gender between Gaeta et al. [14] and our study, because
the effect of drugs varies with gender. In addition, we worked with
younger animals (aged nine weeks when verapamil was adminis-
tered), while Gaeta et al. [14] used mice aged 16 and 48 weeks.
On average, no treatment induced unsafe blood glucose levels
(limit 63–176 mg/dl). After two days with a ketogenic diet, BGLs
decreased as expected compared with baseline (Table 2). Although
Tupper et al. [23] did not observe changes in BGLs in C57BL/6
mice after 12 hours on a ketogenic diet, 129 mice showed reduced
BGLs (74620 mg/dl) similar to that found in the present study
after 48 hours (75.7625.7 mg/dl).
The hypothesis of Experiment B was that suppression of
myocardial uptake of 18F-FDG would enhance the visualization of
nearby lesions, thus improving the diagnosis of several conditions
Table 1. Image assessment of myocardial uptake of 18F-FDG.
Likert scale Post-Verapamil Post-Seeds Post-KD
0 (homogeneously minimal) 0 4 7
1 (mostly minimal) 2 4 3
2 (mostly intense) 4 2 0
3 (homogeneously intense) 4 0 0
After each treatment animals were divided into four groups based on visual myocardial 18F-FDG uptake (see Fig. 2).
doi:10.1371/journal.pone.0107999.t001
Figure 3. Plots of standardized uptake values mean (SUV) of
left ventricular myocardium after each treatment. p values were
calculated using the Sidak post hoc test (*p = 0.015, {p = 0.008,
**p = 0.007and {{p= 0.003).
doi:10.1371/journal.pone.0107999.g003
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such as infective endocarditis, coronary atherosclerotic lesions, and
some metastatic lesions. Therefore, we tested the best protocol
from Experiment A in a lung inflammation model generated in
animals by tracheal administration of LPS. Visualization improved
after two days on a ketogenic diet; according to the results of our
previous experiments, this was the best approach to reducing
myocardial uptake of 18F-FDG. PET images after administration
of LPS showed that hot areas near the heart were more easily
identified (Fig. 4D) when myocardial uptake was completely
suppressed. Conversely, in animals in which myocardial uptake
was not or only partially suppressed, it was much harder to
distinguish inflammation from myocardial spillover (Fig. 4B–C).
Lesion/myocardium ratio also improved in the animals with
complete suppression compared with partial or null suppression,
due to a lower background near the lesions (the heart). Although
adherence is not, in theory, an issue in animal studies, palatability
could affect animal food consumption. In addition, it is possible
that the marked distress observed in the LPS animals changed
their food consumption. Severe pulmonary distress could also have
led to an increase in cardiac metabolic needs, forcing a switch to
glucose as the metabolic substrate. Moreover, pulmonary distress
may also lead to myocardial hypoxia. When the oxygen supply
decreases, the heart protects itself by switching energy production
to glycolysis [25], resulting in increased 18F-FDG uptake, as
reported by McNulty et al. [26]. This could explain why the
ketogenic diet was less effective in the LPS-challenged mice than in
healthy animals. Therefore, the LPS model was not optimal for
demonstrating the efficacy of the diet in reducing myocardial
uptake of 18F-FDG. Nevertheless, the efficacy of the diet was well
demonstrated in healthy animals. The LPS model was solely
intended to illustrate better visualization of pulmonary lesions
when myocardial uptake is suppressed. Our study provides the first
validation of this methodology in animal studies, although
previous clinical studies have examined the usefulness of high-fat
protocols to visualize inflammation in coronary arteries [9] or
metastases [5].
Several studies have evaluated the effect of high-fat diets on
inflammatory diseases, such as atherosclerosis. In rodents,
inflammatory gene expression is modified after six to ten weeks
on a high-fat diet [27,28]. Erridge et al. [29] reported an increase
in circulating plasma endotoxin after a high-fat meal in healthy
subjects; this endotoxin may be associated with the risk of
atherosclerosis. As for 18F-FDG uptake, some authors have shown
that hypercholesterolemia and age (which is equivalent to the
duration of cholesterol loading) were consistently correlated with
18F-FDG uptake in large arteries in patients [30] and in the mouse
aorta [31]. Thus, although we did not analyze the effects of
ketogenic diet on 18F-FDG uptake in inflamed tissues, Williams
and Kolodny [5] reported no differences in uptake between low-
carbohydrate, high-fat diets and fasting (p = 0.30; SUVrange 1.8–
5.6) in patients with chronic inflammation (osteoarthritis, tendini-
tis, dental). We cannot rule out the possibility that a high-fat diet
can exacerbate lung inflammation and thus induce an increase in
18F-FDG uptake that further improves the signal-to-noise ratio.
Notwithstanding, in order to better visualize this kind of lesion
near the heart, it is still necessary to reduce myocardial uptake of
18F-FDG.
Interpretation of the data in this study is limited by the fact that
the animal experiments were not randomized. Thus, treatments
were always tested following the same order (baseline, verapamil,
ketogenic diet, and sunflower seeds for experiment A). Although
the optimal withdrawal period between treatments is unknown,
fatty acid metabolism is suppressed when insulin levels increase
after a regular meal [32], and the mean elimination half-life in
single-dose administration of verapamil ranges from three to seven
hours [33]. For these reasons, we thought a delay of four days
between treatments would be more than sufficient, although there
is no complete guarantee that this is so. Even though we know that
Table 2. Blood glucose level (BGL) before 18F-FDG administration.
Treatment BGL, mg/dl
Baseline 110.7621.3
Post-Verapamil 121.5616.9
Post-KD 75.7625.7*{
Post-seeds 91.1633.0
Mean BGL (6 SD). p values were calculated using the Sidak post hoc test (*p = 0.04 vs. baseline; {p= 0.004 vs. verapamil).
doi:10.1371/journal.pone.0107999.t002
Figure 4. Lung inflammation visualized by 18F-FDG-PET. (A) Control PET scan after regular diet in a non–LPS-challenged animal. Lungs do not
show 18F-FDG uptake. (B–D) LPS-challenged animals after two days of ketogenic diet. (B) Null suppression of myocardial uptake. (C) Partial
suppression of myocardial uptake. In the case of null or partial suppression, it is much harder to distinguish inflammation from myocardial spillover
(arrows). (D) Complete suppression improves hot areas identification.
doi:10.1371/journal.pone.0107999.g004
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myocardial uptake can sometimes be reduced by fasting, we did
not follow this approach, because in our experience and in the
experience of other researchers, it is often not effective [5,8,23].
This is also the main reason why we decided not to include a
control group when we evaluated the ketogenic diet in the lung
inflammation study (Experiment B). We did not measure food
intake per animal, and this prevented us from studying the
relationship between total dietary consumption and myocardial
uptake of 18F-FDG. We also did not measure ketone bodies in the
blood stream, which according to some authors might affect 18F-
FDG uptake [24,34,35]. We were also not able to comment on
cardiac glucose metabolism, because we did not measure the
necessary specific parameters such as levels of glucose, insulin, and
lactate or oxygen consumption. A final limitation was the relatively
high dose of LPS (5 mg/kg), which, as mentioned above, produced
severe pulmonary distress. This may have reduced the efficiency of
ketogenic diet in the LPS mice compared to the healthy mice. A
lower LPS dose might have maintained the efficacy of ketogenic
diet.
In conclusion, these results show that two days on high-fat diets
prior to 18F-FDG-PET imaging suppresses myocardial uptake in
mice better than verapamil. Although a sunflower seed diet was
slightly less effective than a ketogenic diet, it is much more
affordable, thus making it a potentially good alternative in some
situations. Our findings also demonstrate that a ketogenic diet
improves visualization of inflammatory lesions near the heart.
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